Vetsina Animal Diagnostics Appoints Simon Wheeler As Its First CEO
Vetsina Animal Diagnostics – the new company formed by Roslin Technologies and DESTINA Genomics – has announced the appointment of Dr. Simon Wheeler as its first Chief Executive Officer (CEO).
Dr. Wheeler is a veterinarian and strategic leader with over 20 years’ experience of the global animal health industry. He has previously held strategic, technical, marketing and innovation roles in various companies, including Pharmacia and Novartis.
He also reached senior positions in clinical veterinary academia in the UK and US, lecturing at international meetings and conducting research, as well as publishing three books and over 125 articles and chapters, and mentoring trainees. He has received a number of awards for teaching and contributions to veterinary surgery.
“With his range of experience and skills, Simon is a great fit with the position of CEO at this exciting new company,” said Hugh Ilyine, CEO of DESTINA and Executive Director of Vetsina. “We know Vetsina’s development and growth is in good hands.”
Recently, Dr. Wheeler has held several consultancies, including Chief Operating Officer of Roslin Technologies, an Edinburgh-based biotech start up, and he was commercial consultant to Advanced Anaesthesia Specialists. He has supported various biotech companies as well as holding several board positions.
More from Vetsina Animal Diagnostics